Key result
Transcatheter valve-in-valve implantation represents a valid alternative to redo surgery in patients with degenerated bioprostheses and high-risk surgical profiles.
Why the study?
Does transcatheter valve-in-valve implantation provide a safe and effective alternative to redo surgery in high-risk patients with degenerated bioprosthetic aortic and mitral valves?
Does transcatheter valve-in-valve implantation provide a safe and effective alternative to redo surgery in high-risk patients with degenerated bioprosthetic aortic and mitral valves?
Transcatheter valve-in-valve implantation is a valid, minimally invasive alternative to redo surgery for high-risk patients with degenerated bioprostheses.
No takes yet. Share an insight, caveat, or question.
May inform high-risk patient decisions; leaves open need for randomized durability data.
Gallo et al. (2016) conducted a review in Degenerated bioprosthetic aortic and mitral valves. Transcatheter valve-in-valve implantation was evaluated. Transcatheter valve-in-valve implantation represents a valid alternative to redo surgery in patients with degenerated bioprostheses and high-risk surgical profiles.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: